A cardiac antiarrhythmic screening test using the isolated ischaemic perfused rat heart preparation

Area of Science:

• Cardiovascular Pharmacology
• Drug Discovery and Development
• Experimental Cardiology

Background:

• Myocardial ischemia and reperfusion commonly induce ventricular fibrillation.
• Developing effective antiarrhythmic drugs requires reliable screening methods.
• Existing screening methods can be complex, time-consuming, or require arrhythmogenic agents.

Purpose of the Study:

• To establish and validate a novel, simplified screening test for antiarrhythmic drug efficacy.
• To assess the dose-response effectiveness of known antiarrhythmic agents in a specific experimental model.
• To evaluate the feasibility of using an isolated perfused rat heart model for antiarrhythmic drug screening.

Main Methods:

• Ventricular fibrillation was induced in isolated perfused rat hearts via ischemia and reperfusion.
• The effectiveness of propranolol, quinidine, and lidocaine in converting fibrillation to sinus rhythm was determined.
• Dose-response relationships for each tested antiarrhythmic drug were established.

Main Results:

• The isolated perfused rat heart model successfully induced ventricular fibrillation.
• Propranolol, quinidine, and lidocaine demonstrated dose-dependent effectiveness in converting ventricular fibrillation to sinus rhythm.
• The experimental procedure was found to be straightforward, requiring minimal surgical skill and observation time.

Conclusions:

• The isolated perfused rat heart model serves as a simple and effective platform for antiarrhythmic drug screening.
• This method avoids the need for arrhythmogenic drugs and requires minimal substance quantities.
• The proposed test is a viable alternative for preclinical screening of novel antiarrhythmic compounds.